Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
BioGaia Community
OM:BIOG B Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
BioGaia
Popular
Undervalued
Overvalued
BioGaia
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding North American Demand Will Unlock New Health Trends
Key Takeaways Expansion in direct sales and mainstream retail channels supports sustained growth as preventative health trends and demand for natural, clinically-proven products intensify globally. Increased investment in innovation, marketing, and clinical research is expected to drive margin expansion and diversification despite short-term earnings pressure.
View narrative
SEK 140.00
FV
32.5% undervalued
intrinsic discount
11.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
BIOG B
BIOG B
BioGaia
Your Fair Value
SEK
Current Price
SEK 94.50
24.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 2.4b
Earnings SEK 485.0m
Advanced
Set Fair Value